MedTrace Logo

Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas (2)

NCT01097447 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 2619

Last updated 2018-10-11

No results posted yet for this study

Summary

To evaluate the efficacy of ultraviolet-A (UVA)-induced cross-linking of corneal collagen (CXL) as a method to increase the biomechanical and biochemical stability of the cornea by inducing additional cross-links within or between collagen fibers using UVA light and the photo- mediator riboflavin. The purpose of this study is to generate data for presentation at medical meetings and for peer-review publication

Conditions

  • Keratoconus
  • Ectasia
  • Degeneration

Sponsors & Collaborators

  • Cxlusa

    lead INDUSTRY

Principal Investigators

  • Parag Majmudar, MD · Chicago Cornea Consultants, LTD

  • Lance Forstot, MD · Corneal Consultants of Colorado, P.C

  • Bradley Bowman, M.D · Cornea Associates of Texas

  • Sandy Feldman, M.D · Clear View Eye & Laser Medical Center

  • Sherman Reeves, MD · Minnesota Eye Consultants, P.A.

Eligibility

Min Age
8 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-01
Primary Completion
2017-04-30
Completion
2017-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01097447 on ClinicalTrials.gov